1 - 5 out of 5Page size: 10
  1. 2025

  2. Vasculogenic mimicry in non-small cell lung cancer: a systematic review

    Shapkina, V., Shindyapin, V., Burlov, N., Prosekina, E. & Artemyeva, A., 25 Jul 2025, In: Frontiers in Oncology. 15, 1481726.

    Research output: Contribution to journal › Article › peer-review

  3. Баланс между обманом и адаптацией: васкулогенная мимикрия как стратегия выживания опухоли

    Prosekina, E. A., Shapkina, V. A., Karpov, A. E., Fedorutseva, E. Y. & Artemyeva, A. S., 14 Apr 2025, In: Успехи молекулярной онкологии. 12, 1, p. 14-30 17 p.

    Research output: Contribution to journal › Article › peer-review

  4. Белок DDAH1: биологические функции, роль в процессах канцерогенеза

    Prosekina, E. A., Shapkina, V. A., Karpov, A. E., Fedorutseva, E. Y. & Artemyeva, A. S., 12 Feb 2025, In: АРХИВ ПАТОЛОГИИ. 87, 1, p. 60-67 8 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2020

  6. 3D-models creation based on solid tumor cell lines for assessment of antitumor treatment.

    Prosekina, E. & Danilova, A., 2020, p. 509-510.

    Research output: Contribution to conference › Abstract

  7. Clinical and immunological characteristics of patients sarcomas with different clonogenicpotential.

    Prosekina, E. & Danilova, A., 2020, p. 511.

    Research output: Contribution to conference › Abstract

ID: 29451396